Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. [electronic resource]
Producer: 20120123Description: 1384-1390.e4 p. digitalISSN:- 1556-5653
- Administration, Oral
- Adult
- Double-Blind Method
- Down-Regulation -- drug effects
- Drug Administration Schedule
- Female
- Fertilization in Vitro -- methods
- Gonadotropins -- therapeutic use
- Humans
- Hypoglycemic Agents -- administration & dosage
- Metformin -- administration & dosage
- Ovarian Hyperstimulation Syndrome -- epidemiology
- Ovulation Induction -- methods
- Placebos
- Polycystic Ovary Syndrome -- complications
- Pregnancy
- Risk Factors
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.